Premier is now offering Bioventus’ full surgical orthobiologics product portfolio to its U.S. membership, comprising 3,750 hospitals and >130,000 provider organizations.
The products, used for bone healing and spinal fusion applications, include:
- OSTEOAMP® allograft, available through Premier since 2012
- CELLXTRACT® and EXTRACTOR™ autologous cell and marrow extraction devices
- EXPONENT™ demineralized bone matrix
- INTERFACE bioactive bone graft
- OSTEOMATRIX® biphasic mineral/collagen bone graft
- OSTEOPLUS® biphasic mineral bone graft
- PUREBONE® demineralized cancellous bone and cancellous chips
- SIGNAFUSE™ bioactive bone graft substitute
Source: Bioventus LLC
Premier is now offering Bioventus' full surgical orthobiologics product portfolio to its U.S. membership, comprising 3,750 hospitals and >130,000 provider organizations.
The products, used for bone healing and spinal fusion applications, include:
OSTEOAMP® allograft, available through Premier since 2012
CELLXTRACT® and...
Premier is now offering Bioventus’ full surgical orthobiologics product portfolio to its U.S. membership, comprising 3,750 hospitals and >130,000 provider organizations.
The products, used for bone healing and spinal fusion applications, include:
- OSTEOAMP® allograft, available through Premier since 2012
- CELLXTRACT® and EXTRACTOR™ autologous cell and marrow extraction devices
- EXPONENT™ demineralized bone matrix
- INTERFACE bioactive bone graft
- OSTEOMATRIX® biphasic mineral/collagen bone graft
- OSTEOPLUS® biphasic mineral bone graft
- PUREBONE® demineralized cancellous bone and cancellous chips
- SIGNAFUSE™ bioactive bone graft substitute
Source: Bioventus LLC
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





